The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients
Objectives:. The recent conflicting data on the mortality benefit of neuromuscular blocking agents in acute respiratory distress syndrome and the potential adverse effects of continuous neuromuscular blocking agent necessitates that these medications should be used judiciously with dose reduction in...
Main Authors: | Sarah Hadique, MD, Varun Badami, MD, Michael Forte, MD, Nicole Kovacic, PharmD, BCCCP, Amna Umer, PhD, Amanda Shigle, PharmD, Jordan Gardo, BSN, RN, CCRN, Rahul Sangani, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-03-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000371 |
Similar Items
-
Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
by: Michael Behal, PharmD, et al.
Published: (2021-07-01) -
Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
by: Mary P. Kovacevic, PharmD, BCCCP, BCPS, et al.
Published: (2021-01-01) -
Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
by: Shahideh Amini, PharmD, et al.
Published: (2020-01-01) -
Real-World Observational Review of Andexanet Alfa Prescribing and Utilization Outcomes at a Community Teaching Hospital
by: Kristine A. Sobolewski, PharmD, BCPS, et al.
Published: (2021-04-01) -
Fibrinogen Concentrate for the Treatment of Thrombolysis-Associated Hemorrhage in Adult Ischemic Stroke Patients
by: Megan E. Barra PharmD, BCPS, BCCCP, et al.
Published: (2020-09-01)